ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Johnson Matthey says it will close its drug chemical plant in Conshohocken, Pa., by the end of the year, claiming the facility does not comport with a focus on “complex, high-value, low-volume specialty products” in its health care business. The British firm more than doubled its controlled-substance manufacturing capacity when it acquired the plant from Lonza in 2011. The closure will eliminate 80 jobs, according to Matthey.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter